Back to NRIX
Elmind Capital, LP NRIX Position History
Nurix Therapeutics, Inc.
Quarters held
4
Latest value
$10.9M
Q3 2026
Peak value
$11.2M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $8.7M |
| Q1 2026 | $7.1M |
| Q2 2026 | $11.2M |
| Q3 2026 | $10.9M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $10.9M | 460.0K | — | — |
| Q2 2026 | $11.2M | 460.0K | — | — |
| Q1 2026 | $7.1M | 460.0K | — | — |
| Q4 2025 | $8.7M | 460.0K | — | — |
Other funds holding NRIX
$195.3M
$187.7M
$187.3M
$175.3M
$166.6M
$164.8M
$153.5M
$142.3M